Evidence map›Paper›PMID 25126546›Full record

ArticleBioMed research international2014

Genome-wide uncovering of STAT3-mediated miRNA expression profiles in colorectal cancer cell lines.

Jufeng Zhang, Xia Luo, Huiming Li, Ling Deng, Ying Wang

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. PIM Kinase as an Executional Target in Cancer.Journal of cancer prevention · 2018
    Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Jufeng ZhangSchool of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Xia LuoCollege of Engineering, South China Agricultural University, Guangzhou 510642, China.
Huiming LiExperimental Research Center, First People's Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200080, China.
Ling DengSchool of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Ying WangBiomedical Research Institute, Shenzhen PKU-HKUST Medical Center, No. 1120, Lianhua Road, Futian District, Shenzhen 518036, China.ORCID 0000-0001-6195-8202
Guangdong Pharmaceutical University · CNHKUST Shenzhen Research Institute · CNShanghai First People's Hospital · CNSouth China Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is one of the most common malignancies resulting in high mortality worldwide. Signal transducer and activator of transcription 3 (STAT3) is an oncogenic transcription factor which is frequently activated and aberrantly expressed in CRC. MicroRNAs (miRNAs) are a class of small noncoding RNAs which play important roles in many cancers. However, little is known about the global miRNA profiles mediated by STAT3 in CRC cells. In the present study, we applied RNA interference to inhibit STAT3 expression and profiled the miRNA expression levels regulated by STAT3 in CRC cell lines with deep sequencing. We found that 26 and 21 known miRNAs were significantly overexpressed and downexpressed, respectively, in the STAT3-knockdown CRC cell line SW480 (SW480/STAT3-siRNA) compared to SW480 transfected with scrambled siRNAs (SW480/siRNA-control). The miRNA expression profiling was then validated by quantitative real-time PCR for selected known miRNAs. We further predicted the putative target genes for the dysregulated miRNAs and carried out functional annotation including GO enrichment and KEGG pathway analysis for selected miRNA targets. This study directly depicts STAT3-mediated miRNA profiles in CRC cells, which provides a possible way to discover biomarkers for CRC therapy.

Indexed as

Cell Line, TumorCell ProliferationColorectal NeoplasmsGene Expression ProfilingGene Expression Regulation, NeoplasticGene Knockdown TechniquesHumansMicroRNAsMolecular Targeted TherapySTAT3 Transcription FactorMicroRNAsSTAT3 protein, humanSTAT3 Transcription Factor

Identifiers

PMID25126546
PMCPMC4121995
OpenAlexW1983759912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.